Taysha Gene Therapies
TSHA
#5807
Rank
ยฃ0.93 B
Marketcap
ยฃ2.88
Share price
-5.51%
Change (1 day)
-5.59%
Change (1 year)

EPS for Taysha Gene Therapies (TSHA)

EPS in 2026 (TTM): -ยฃ0.32

According to Taysha Gene Therapies's latest financial reports the company's current EPS (TTM) is -ยฃ0.33. In 2022 the company made an earnings per share (EPS) of -ยฃ2.91 an increase over its 2021 EPS that were of -ยฃ3.54.

EPS history for Taysha Gene Therapies from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.32
2022-ยฃ2.91-17.71%
2021-ยฃ3.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ1.03 213.95%๐Ÿ‡บ๐Ÿ‡ธ USA